Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 360 is a processed pseudogene derived from the 5S ribosomal RNA gene located on human chromosome 12[4][7]. Unlike functional 5S rRNA genes, pseudogenes such as RNA5SP360 acquire disabling mutations and typically do not have protein-coding or canonical functional roles. While pseudogenes were historically considered functionless, some can be transcribed and may participate in regulatory RNA networks or have subtle influences on gene expression[2]. There is no experimental evidence that RNA5SP360 is transcribed or plays a direct functional or pathological role. It is included in the genome as a non-functional remnant of gene duplication and retrotransposition events[6][2][7]. It is not considered a therapeutic target or clinically actionable gene as of current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 360 (RNA5SP360).